ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Plasma proteins Transporters
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | | | | | | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | | | Expressed in all |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF4B | Eukaryotic translation initiation factor 4B | | | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FOXO1 | Forkhead box O1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXO3 | Forkhead box O3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GLUL | Glutamate-ammonia ligase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
HADHA | Hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
HDAC5 | Histone deacetylase 5 | Cancer-related genes Enzymes
| | | | | Expressed in all |
HIF1A | Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
HMGN3 | High mobility group nucleosomal binding domain 3 | | | | | | Expressed in all |
HTT | Huntingtin | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IQGAP1 | IQ motif containing GTPase activating protein 1 | Plasma proteins
| | | | | Expressed in all |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
LPIN2 | Lipin 2 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MCU | Mitochondrial calcium uniporter | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
NDUFAF2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 2 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
NKX6-1 | NK6 homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PAK1 | P21 protein (Cdc42/Rac)-activated kinase 1 | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PARP1 | Poly (ADP-ribose) polymerase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PASK | PAS domain containing serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
PC | Pyruvate carboxylase | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PDK2 | Pyruvate dehydrogenase kinase, isozyme 2 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
PKN1 | Protein kinase N1 | Enzymes
| | | | | Expressed in all |
PPP3CA | Protein phosphatase 3, catalytic subunit, alpha isozyme | Enzymes Plasma proteins
| | | | | Expressed in all |
PRKAB1 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit | FDA approved drug targets
| | | | | Expressed in all |